With over US$ 1.5 trillion under management, Fidelity is an affiliation of two separate, privately owned companies: FMR, LLC within the United States and FIL Limited outside the United States. Fidelity has fund management and research capabilities in over 35 countries, serving more than 20 million customers.

As one of the world's largest institutional investors, with over 4,500 company visits each year, Fidelity has unique access to the world's top business executives in all major industries.

Fidelity has a strong network of investment managers and advisors globally that have the expertise and knowledge to understand macro trends and their implications for the local environment. Our investment decisions are made by an international committee with several decades of investing experience worldwide.  Our global footprint helps our partner companies access opportunities in new markets and geographies. We also bring deep global business insights to help our partners succeed in world markets.

Global Venture / Growth Capital

Fidelity is an active private equity investor with 40+ years experience through three other international funds. The Fidelity family of PE / VC funds carries out 25-30 transactions annually.

In the US, Fidelity has invested in hundreds of companies in the technology sector since 1969, and many of those portfolio companies, such as MCI, Rolm, Airespace, Qumas and Continental Cablevision have become, or have been acquired by, industry leaders. Today Fidelity Growth Partners Europe (www.fidelitygrowthpartners.eu) continues that mission with a focus on investing in venture growth companies in Europe. Our investment team in London has decades of experience operating, advising, and investing in fast growing European technology companies. Portfolio companies include Asset Control, Cúram Software, Innogames, Neverfail, NewBay, QUMAS, and Seatwave.

Fidelity Biosciences (www.fidelitybiosciences.com), based in Boston, has a portfolio of several promising early-stage biopharmaceutical and medical technology companies, including FoldRx, Mersana Therapeutics, Ironwood and US Genomics.

Fidelity Growth Partners Asia (http://www.fidelitygrowthpartners.asia ) has actively invested in both the information technology and healthcare sectors in Asia for more than 15 years. Portfolio companies include: Alibaba (HKG: 1688), Hurray (NASDAQ: HRAY), AsiaInfo (NASDAQ: ASIA),  Wuxi Pharmatech (NYSE: WX), iSoftstone, Crystal Computer Graphics, Wisers and Asia Renal Care. Our investment advisors in Hong Kong, Beijing and Shanghai have decades of experience in the Asia-Pacific region.

Fidelity Growth Partners India (http://www.fidelitygrowthpartners.in) is focused on growth capital investing across multiple sectors in India.  Portfolio companies include: NetMagic, Coastal Projects Private Limited, VMC, Manthan Systems, PL Engineering. Our investment advisors in Mumbai have significant experience and understanding of the opportunities and challenges of managing growth-stage companies in India's dynamic markets.